Pharmacist Barbara Violo shows off a vial of the Oxford-AstraZeneca COVID-19 vaccine in Toronto on Friday, March 12, 2021. THE CANADIAN PRESS/Nathan Denette
Four people in Canada have now died from a rare blood-clotting event linked to the Oxford-AstraZeneca COVID-19 vaccine.
The latest person was in their 50s in New Brunswick.
The province's chief medical officer of health, Dr. Jennifer Russell, says the person received a first dose of AstraZeneca on April 11th.
They developed blood clot symptoms 17 days later and died recently.
This latest death comes as Ontario is resuming use of the vaccine, but only as a second dose.
More than 2.1-million Canadians have received at least one dose of the AstraZeneca vaccine.